Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

NCT00062023 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Study closed by the NCI.

Conditions

Colorectal Cancer

Interventions

DRUG: Acetylsalicylic acid (Aspirin)
DRUG: Sulindac
DRUG: Ursodiol
OTHER: Sulindac Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]